CCI vs COLL
Crown Castle (CCI) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the CCI and COLL stock pages for the full models.
Not investment advice.